The relationship between cardiovascular and all-cause mortality and obesity in people with diabetes is still controversial. We investigated the association of body mass index (BMI) with the risk of major adverse cardiovascular events (MACE) and all-cause mortality in people with diabetes. 
INTRODUCTION
Cardiovascular complications occur more commonly in people with diabetes. 1 The association between obesity and an increased risk of cardiovascular disease (CVD) is well established in the general population. 2, 3 Although major adverse cardiovascular events (MACE) are critical health endpoints among people with diabetes, little is known about the relationship between body mass index (BMI) and MACE in people with diabetes. [4] [5] [6] [7] There has been an ongoing debate over the relationship between BMI and mortality in people with diabetes. Many observational studies have reported an "obesity paradox" in diabetics, indicating that people with diabetes and an elevated BMI have lower mortality rates than those with BMIs that are considered to reflect normal weight. [8] [9] [10] [11] On the other hand, a recent large cohort study suggested a J-shaped association between BMI at the time of diabetes diagnosis and all-cause mortality, with the lowest risk observed among participants of normal weight.
Health Insurance Service-National Health Screening Cohort (NHIS-HEALS).
METHODS

Study participants
The Korean NHIS, a compulsory single-payer national health care insurance system, covers 98% of the population residing within the territory of Korea, and it administers all databases on health 
Outcomes
The outcomes of the analysis were incidence of MACE and allcause mortality. We defined MACE as a composite of hospitalization for myocardial infarction (ICD-10 codes I21−I22), stroke (ICD-10 codes I60−I69 or G45.9), and cardiovascular death (ICD-10 codes I00−I99). All-cause mortality and cardiovascular death were defined by death status in the NHIS database, which was linked to the National Death Registry using unique resident registration numbers.
Statistical analyses
Normally distributed data are presented as mean ± standard de- 
RESULTS
In total, 48,438 people (male, 58.1%; median age, 56.1 years)
were included in the analysis. Table 1 summarizes the baseline characteristics of people with diabetes stratified by baseline BMI.
People with a higher BMI at baseline had higher systolic blood pressure, diastolic blood pressure, and total cholesterol, whereas they had lower fasting glucose. However, people with BMIs in the underweight range were the oldest (mean ± SD, 60.3 ± 11.0 years), and this group had the highest proportions of males, current smokers, those engaged in low levels of physical activity, and insulin users.
People classified as obese class II were the youngest (mean ± SD, 54.9 ± 9.2 years); this group had the highest proportions of females, Table 3 shows all-cause mortality according to BMI group. In an unadjusted model, people with an underweight BMI had a significantly higher risk of all-cause mortality than did those with a nor- Fig. 1 ).
DISCUSSION
In this analysis of nationwide follow-up data on Korean adults, overweight and obese people had a lower risk for MACE and allcause mortality in people with diabetes. When classified by the specific subtype of MACE, underweight people had a higher risk for cardiovascular death and myocardial infarction than those with the normal-weight classification. However, overweight and obese people had a lower risk for cardiovascular death and stroke.
Previous studies reported that obesity had adverse effects on CVD. ) people had a higher risk of CVD compared with those classified as normal-weight in the Swedish National Diabetes Register study. 15 Although overweight and obesity have adverse effects on CVDs, many studies suggest an obesity paradox in which overweight and obese people have a better prognosis for CVD than underweight people. 16 The mechanisms for this paradox are unclear.
However, some characteristics of obese people, such as younger age, lower prevalence of smoking, and use of cardiac medications for high blood pressure, may explain a lower risk of CVD. 16 Our study also showed that obese people were younger-aged; had higher blood pressure; were more likely to use medication such as an anti-hypertensive, statin, or anti-platelet; and were less likely to smoke. Thus, use of drugs and lifestyle modifications by obese people may affect the risk of MACE, although we controlled for these factors.
Several mechanisms may explain the observed higher risk for MACE associated with underweight BMI. First, increased fat, if
properly distributed, can provide some benefits. Several studies have suggested that subcutaneous peripheral fat has a cardioprotective effect. [17] [18] [19] It may act as a "metabolic sink, " removing dietary triglycerides. 20, 21 Second, muscle mass prevents insulin resistance and therefore has a protective effect in CVD. However, underweight people may have low muscle mass, as BMI is positively correlated with muscle mass, particularly in the elderly. 22 In this study, the underweight group was less physically active than the higher BMI groups. Third, genetic hypotheses can explain the advantages observed in the group categorized as obese. Underweight and normalweight BMI people with diabetes may be genetically predisposed to a higher risk of cardiovascular events. 8 We found that the groups with an overweight and obese BMI had lower all-cause mortality than the normal-weight BMI group; however, the highest mortality was in the underweight BMI group.
Conflicting results have been reported regarding obesity and allcause mortality. In particular, a previous study reported improvements in the long-term outcomes of CVD in obese diabetic people after bariatric surgery. 23 However, the causes underlying the beneficial effects of bariatric surgery are not limited to weight reduction. 24 Additionally, the Look Action for Health in Diabetes trial, a multicenter randomized controlled trial, concluded that an intensive lifestyle intervention focused on weight loss improved glycemic control but did not reduce the rate of cardiovascular events. 25 Additionally, Tobias et al. 12 suggested that the obesity paradox can be explained by reverse causality or confounding factors; thus, restricting the analysis to people with incident diabetes and excluding people, such as smokers, those 65 years of age or older, and those with known illnesses at baseline, are imperative for reducing bias. However, previous studies attempted to remove bias and found that the obesity paradox still existed among people with diabetes. 26, 27 Although we did not consider important factors, such as the duration of diabetes or glycated hemoglobin levels, we also observed the obesity paradox after adjusting for confounding factors, such as sex, age, hypertension, and use of glucose-lowering drugs, using a stratification analysis.
This study had several limitations that should be addressed. First, the outcomes in this study were based on diagnoses obtained from health insurance claims data. Although previous validation studies for the identification of CVD events showed positive rates of 71.4%
for myocardial infarction and 83.4% for ischemic stroke, there were potential disease misclassifications, biasing the observed difference- fore, most data can be attributed to people with T2DM. 30 Finally, although statistical adjustments were performed, some important potential confounders (e.g., weight change, central obesity, duration of diabetes, severity of diabetes) were not considered; thus, the possibility of residual confounding effects remains.
In conclusion, in people with diabetes, underweight people had a higher risk for all-cause mortality, whereas overweight or obese people had a lower risk for MACE and all-cause mortality than those of normal weight.
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